Literature DB >> 14735583

Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin-1 gene.

Vincent des Portes1, Nathalie Boddaert, Silvia Sacco, Sylvain Briault, Kim Maincent, Nadia Bahi, Marie Gomot, Nathalie Ronce, Joseph Bursztyn, Catherine Adamsbaum, Monica Zilbovicius, Jamel Chelly, Claude Moraine.   

Abstract

Oligophrenin-1 (OPHN-1) gene disruption is known as responsible for so called "non-specific" X-linked mental retardation (MR) Billuart et al. [1998: Nature 392:923-926]. In order to search for a possible specific clinical and radiological profile for mutation in the OPHN-1 gene, clinical and 3D brain MRI studies were performed in the two families with a known mutation in OPHN-1 reported so far: a 19-year-old female with an X;12 balanced translocation encompassing OPHN-1, and four affected males of family MRX60 sharing a frameshift mutation in OPHN-1. Clinical data shared by affected individuals were neonatal hypotonia with motor delay but no obvious ataxia, marked strabismus, early onset complex partial seizures, and moderate to severe MR. Brain MRIs performed in three individuals exhibited a specific vermian dysgenesis including an incomplete sulcation of anterior and posterior vermis with the most prominent defect in lobules VI and VII. In addition, a non-specific cerebral cortico-subcortical atrophy was also observed. These clinical and radiological features suggest a distinct clinico-radiological syndrome. These preliminary data need to be confirmed in other families and will be helpful for further targeted mutation screening of the OPHN-1 gene in male patients with similar clinico-radiological features. In addition, OPHN-1 inactivation should be considered as a relevant model of developmental vermis disorganization, leading to a better understanding of the possible role of the cerebellum in MR. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735583     DOI: 10.1002/ajmg.a.20422

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery.

Authors:  Nael Nadif Kasri; Akiko Nakano-Kobayashi; Linda Van Aelst
Journal:  Neuron       Date:  2011-10-20       Impact factor: 17.173

2.  ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.

Authors:  Irene Busti; Manuela Allegra; Cristina Spalletti; Chiara Panzi; Laura Restani; Pierre Billuart; Matteo Caleo
Journal:  J Neurosci       Date:  2020-02-25       Impact factor: 6.167

3.  Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity.

Authors:  Malik Khelfaoui; Cécile Denis; Elly van Galen; Frédéric de Bock; Alain Schmitt; Christophe Houbron; Elise Morice; Bruno Giros; Ger Ramakers; Laurent Fagni; Jamel Chelly; Marika Nosten-Bertrand; Pierre Billuart
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

4.  The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors.

Authors:  Nael Nadif Kasri; Akiko Nakano-Kobayashi; Roberto Malinow; Bo Li; Linda Van Aelst
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

5.  Characterization of oligophrenin-1, a RhoGAP lost in patients affected with mental retardation: lentiviral injection in organotypic brain slice cultures.

Authors:  Nael Nadif Kasri; Eve-Ellen Govek; Linda Van Aelst
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

6.  Report of a female patient with mental retardation and tall stature due to a chromosomal rearrangement disrupting the OPHN1 gene on Xq12.

Authors:  Björn Menten; Karen Buysse; Stefan Vermeulen; Valerie Meersschaut; Jo Vandesompele; Bee L Ng; Nigel P Carter; Geert R Mortier; Frank Speleman
Journal:  Eur J Med Genet       Date:  2007-08-06       Impact factor: 2.708

Review 7.  Regulation of the postsynaptic cytoskeleton: roles in development, plasticity, and disorders.

Authors:  Tatyana Svitkina; Wan-Hsin Lin; Donna J Webb; Ryohei Yasuda; Gary A Wayman; Linda Van Aelst; Scott H Soderling
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

Review 8.  X-linked disorders with cerebellar dysgenesis.

Authors:  Ginevra Zanni; Enrico S Bertini
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

9.  Oligophrenin-1 moderates behavioral responses to stress by regulating parvalbumin interneuron activity in the medial prefrontal cortex.

Authors:  Minghui Wang; Nicholas B Gallo; Yilin Tai; Bo Li; Linda Van Aelst
Journal:  Neuron       Date:  2021-04-07       Impact factor: 18.688

10.  Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation.

Authors:  Malik Khelfaoui; Alice Pavlowsky; Andrew D Powell; Pamela Valnegri; Kenneth W Cheong; Yann Blandin; Maria Passafaro; John G R Jefferys; Jamel Chelly; Pierre Billuart
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.